The Dutch CONCOVID Trial intended to look at the effect of convalescent plasma therapy on mortality in COVID-19 patients. It has recently been halted after recruiting only about a fifth of its calculated sample size after some very unexpected results were observed. These are my quick thoughts on the matter!
COVID-19 has had a slow growth in various African countries. I look at the reported numbers and it seems that although the epidemiological proportions are in agreement with the global numbers, the low rate of testing is perhaps contributing to the lower number of reported cases.
India enters a small group of nations which have tested over 1 million samples for COVID-19. Some reflections on the scale of the success and what it entails.
A modeling paper discussing the impact of lock down has been virally transmitted on WhatsApp. In this post, I outline why I disagree with the core findings and assumptions of the model.
My reflections on why we need to mount a community-owned action plan to combat COVID-19 and how it will be detrimental to depend on our secondary and tertiary care hospitals to fight the COVID-19 battle.
